×
S&P 500   3,853.67 (+0.58%)
DOW   31,114.59 (+0.47%)
QQQ   286.97 (+0.00%)
AAPL   142.31 (+0.53%)
MSFT   264.68 (+0.70%)
META   168.34 (+0.09%)
GOOGL   2,270.00 (+0.21%)
AMZN   113.85 (+0.31%)
TSLA   687.34 (-1.70%)
NVDA   150.65 (+0.67%)
NIO   20.49 (-7.62%)
BABA   116.97 (-2.63%)
AMD   74.87 (-0.44%)
MU   57.29 (+0.99%)
CGC   2.64 (-2.58%)
T   21.03 (-0.66%)
GE   61.45 (-0.94%)
F   11.02 (-1.61%)
DIS   95.60 (-1.63%)
AMC   12.35 (-3.36%)
PFE   52.07 (+0.83%)
PYPL   72.97 (-1.92%)
NFLX   183.12 (-1.48%)
S&P 500   3,853.67 (+0.58%)
DOW   31,114.59 (+0.47%)
QQQ   286.97 (+0.00%)
AAPL   142.31 (+0.53%)
MSFT   264.68 (+0.70%)
META   168.34 (+0.09%)
GOOGL   2,270.00 (+0.21%)
AMZN   113.85 (+0.31%)
TSLA   687.34 (-1.70%)
NVDA   150.65 (+0.67%)
NIO   20.49 (-7.62%)
BABA   116.97 (-2.63%)
AMD   74.87 (-0.44%)
MU   57.29 (+0.99%)
CGC   2.64 (-2.58%)
T   21.03 (-0.66%)
GE   61.45 (-0.94%)
F   11.02 (-1.61%)
DIS   95.60 (-1.63%)
AMC   12.35 (-3.36%)
PFE   52.07 (+0.83%)
PYPL   72.97 (-1.92%)
NFLX   183.12 (-1.48%)
S&P 500   3,853.67 (+0.58%)
DOW   31,114.59 (+0.47%)
QQQ   286.97 (+0.00%)
AAPL   142.31 (+0.53%)
MSFT   264.68 (+0.70%)
META   168.34 (+0.09%)
GOOGL   2,270.00 (+0.21%)
AMZN   113.85 (+0.31%)
TSLA   687.34 (-1.70%)
NVDA   150.65 (+0.67%)
NIO   20.49 (-7.62%)
BABA   116.97 (-2.63%)
AMD   74.87 (-0.44%)
MU   57.29 (+0.99%)
CGC   2.64 (-2.58%)
T   21.03 (-0.66%)
GE   61.45 (-0.94%)
F   11.02 (-1.61%)
DIS   95.60 (-1.63%)
AMC   12.35 (-3.36%)
PFE   52.07 (+0.83%)
PYPL   72.97 (-1.92%)
NFLX   183.12 (-1.48%)
S&P 500   3,853.67 (+0.58%)
DOW   31,114.59 (+0.47%)
QQQ   286.97 (+0.00%)
AAPL   142.31 (+0.53%)
MSFT   264.68 (+0.70%)
META   168.34 (+0.09%)
GOOGL   2,270.00 (+0.21%)
AMZN   113.85 (+0.31%)
TSLA   687.34 (-1.70%)
NVDA   150.65 (+0.67%)
NIO   20.49 (-7.62%)
BABA   116.97 (-2.63%)
AMD   74.87 (-0.44%)
MU   57.29 (+0.99%)
CGC   2.64 (-2.58%)
T   21.03 (-0.66%)
GE   61.45 (-0.94%)
F   11.02 (-1.61%)
DIS   95.60 (-1.63%)
AMC   12.35 (-3.36%)
PFE   52.07 (+0.83%)
PYPL   72.97 (-1.92%)
NFLX   183.12 (-1.48%)
NYSE:COO

Cooper Companies Stock Forecast, Price & News

$311.98
-3.91 (-1.24%)
(As of 07/6/2022 02:20 PM ET)
Add
Compare
Today's Range
$311.43
$317.78
50-Day Range
$301.40
$377.38
52-Week Range
$297.34
$463.59
Volume
8,288 shs
Average Volume
319,722 shs
Market Capitalization
$15.39 billion
P/E Ratio
16.39
Dividend Yield
0.02%
Price Target
$432.89

Cooper Companies MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
38.0% Upside
$432.89 Price Target
Short Interest
Healthy
3.25% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.39
Upright™ Environmental Score
News Sentiment
0.31mentions of Cooper Companies in the last 14 days
Based on 6 Articles This Week
Insider Trading
Selling Shares
$123,165 Sold Last Quarter
Proj. Earnings Growth
13.72%
From $13.19 to $15.00 Per Share

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

2.93 out of 5 stars

Medical Sector

14th out of 1,426 stocks

Ophthalmic Goods Industry

1st out of 7 stocks

30 days | 90 days | 365 days | Advanced Chart

Receive COO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cooper Companies and its competitors with MarketBeat's FREE daily newsletter.

Cooper Companies logo

About Cooper Companies (NYSE:COO) Stock

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

COO Stock News Headlines

Correction: Biden-Inflation story
In a story published June 9, 2022, about inflation, The Associated Press misspelled the last name of shopper Nina Cooper
See More Headlines

Industry, Sector and Symbol

Industry
Ophthalmic goods
Sub-Industry
Health Care Supplies
Sector
Medical
CUSIP
21664840
Employees
12,000
Year Founded
1958

Company Calendar

Last Earnings
6/02/2022
Today
7/06/2022
Next Earnings (Estimated)
9/01/2022
Fiscal Year End
10/31/2022

Price Target and Rating

Average Stock Price Forecast
$432.89
High Stock Price Forecast
$495.00
Low Stock Price Forecast
$380.00
Forecasted Upside/Downside
+38.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.8
Research Coverage
10 Analysts

Profitability

Net Income
$2.94 billion
Pretax Margin
15.96%

Debt

Sales & Book Value

Annual Sales
$2.92 billion
Cash Flow
$19.26 per share
Book Value
$140.80 per share

Miscellaneous

Free Float
48,497,000
Market Cap
$15.39 billion
Optionable
Optionable
Beta
0.92

Social Links















Cooper Companies Frequently Asked Questions

Should I buy or sell Cooper Companies stock right now?

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cooper Companies in the last twelve months. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Cooper Companies stock.
View analyst ratings for Cooper Companies
or view top-rated stocks.

What is Cooper Companies' stock price forecast for 2022?

10 Wall Street research analysts have issued 12 month target prices for Cooper Companies' stock. Their COO stock forecasts range from $380.00 to $495.00. On average, they expect Cooper Companies' stock price to reach $432.89 in the next twelve months. This suggests a possible upside of 38.6% from the stock's current price.
View analysts' price targets for Cooper Companies
or view top-rated stocks among Wall Street analysts.

How has Cooper Companies' stock performed in 2022?

Cooper Companies' stock was trading at $418.94 at the beginning of 2022. Since then, COO stock has decreased by 25.4% and is now trading at $312.43.
View the best growth stocks for 2022 here
.

When is Cooper Companies' next earnings date?

Cooper Companies is scheduled to release its next quarterly earnings announcement on Thursday, September 1st 2022.
View our earnings forecast for Cooper Companies
.

How were Cooper Companies' earnings last quarter?

The Cooper Companies, Inc. (NYSE:COO) released its quarterly earnings results on Thursday, June, 2nd. The medical device company reported $3.24 earnings per share for the quarter, missing the consensus estimate of $3.43 by $0.19. The medical device company had revenue of $829.80 million for the quarter, compared to analysts' expectations of $821.03 million. Cooper Companies had a net margin of 30.20% and a trailing twelve-month return on equity of 9.48%. The business's revenue for the quarter was up 15.3% compared to the same quarter last year. During the same period in the prior year, the business earned $3.38 EPS.
View Cooper Companies' earnings history
.

How often does Cooper Companies pay dividends? What is the dividend yield for Cooper Companies?

Cooper Companies declared a semi-annual dividend on Thursday, December 9th. Stockholders of record on Friday, January 21st will be paid a dividend of $0.03 per share on Wednesday, February 9th. The ex-dividend date of this dividend is Thursday, January 20th.
View Cooper Companies' dividend history
.

Is Cooper Companies a good dividend stock?

Cooper Companies(NYSE:COO) pays an annual dividend of $0.06 per share and currently has a dividend yield of 0.02%. The dividend payout ratio of Cooper Companies is 0.32%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Cooper Companies will have a dividend payout ratio of 0.40% next year. This indicates that Cooper Companies will be able to sustain or increase its dividend.
View Cooper Companies' dividend history.

What guidance has Cooper Companies issued on next quarter's earnings?

Cooper Companies issued an update on its FY 2022 earnings guidance on Thursday, June, 30th. The company provided EPS guidance of $13.09-$13.29 for the period, compared to the consensus earnings per share estimate of $13.74. The company issued revenue guidance of $3.28 billion-$3.31 billion, compared to the consensus revenue estimate of $3.29 billion.

Who are Cooper Companies' key executives?

Cooper Companies' management team includes the following people:

What is Robert S. Weiss' approval rating as Cooper Companies' CEO?

8 employees have rated Cooper Companies CEO Robert S. Weiss on Glassdoor.com. Robert S. Weiss has an approval rating of 80% among Cooper Companies' employees.

What other stocks do shareholders of Cooper Companies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cooper Companies investors own include Boeing (BA), AbbVie (ABBV), NVIDIA (NVDA), Netflix (NFLX), Johnson & Johnson (JNJ), Gilead Sciences (GILD), Intel (INTC), Alibaba Group (BABA), Intuitive Surgical (ISRG) and Mastercard (MA).

What is Cooper Companies' stock symbol?

Cooper Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "COO."

How do I buy shares of Cooper Companies?

Shares of COO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Cooper Companies' stock price today?

One share of COO stock can currently be purchased for approximately $312.43.

How much money does Cooper Companies make?

Cooper Companies (NYSE:COO) has a market capitalization of $15.42 billion and generates $2.92 billion in revenue each year. The medical device company earns $2.94 billion in net income (profit) each year or $19.04 on an earnings per share basis.

How many employees does Cooper Companies have?

Cooper Companies employs 12,000 workers across the globe.

Does Cooper Companies have any subsidiaries?

The following companies are subsidiares of Cooper Companies: CVI Contact Lens India Pvt. Ltd., Cooper Medical Inc., CooperSurgical, CooperSurgical Holdings Ltd., CooperVision (UK) Holdings Ltd., CooperVision Australia Pty Limited, CooperVision Canada Corp., CooperVision Caribbean Corp, CooperVision Distribution SPRL, CooperVision GmbH, CooperVision Iberia SL, CooperVision International Holding Company LP, CooperVision Italia Srl, CooperVision Japan Inc., CooperVision Ltd., CooperVision Manufacturing Costa Rica SRL, CooperVision Manufacturing Limited, CooperVision Nederland B.V. Belgian Branch, CooperVision Nederland BV, CooperVision Nordic AB, CooperVision Optical Trading (Shanghai) Company Ltd., CooperVision Sarl, CooperVision Singapore Pte Ltd., CooperVision do Brasil Ltda, Coopervision, Coopervision S.A. (Pty) Limited, Invitro Genetics Inc., ORIGIO Inc, Ocular Sciences SAS, Origio A/S, Recombine Inc., Reprogenetics LLC, Research Instruments Ltd., Sauflon CL Ltd, Sauflon CL Manufacturing & Trading Kft, Sauflon Pharmaceuticals Ltd., TCC Holdings S.a.r.l., and The Cooper Companies Global Holdings LP.
Read More

When was Cooper Companies founded?

Cooper Companies was founded in 1958.

How can I contact Cooper Companies?

Cooper Companies' mailing address is 6101 Bollinger Canyon Road Suite 500, San Ramon CA, 94583. The official website for Cooper Companies is www.coopercos.com. The medical device company can be reached via phone at (925) 460-3600, via email at ir@cooperco.com, or via fax at 925-460-3649.

This page (NYSE:COO) was last updated on 7/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.